AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 14636902 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (50 to 200 mg/day)
Number of subjects: 369
Study 14636902 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 369
Study 10819825 — intervention group
Group type: EXPERIMENTAL
Intervention: 3‐day diet containing at least 150 g carbohydrate per day
Number of subjects: 20
Study 10819825 — intervention group
Group type: COMPARATOR
Intervention: No dietary restrictions
Number of subjects: 20
Study 8859396 — intervention group
Group type: EXPERIMENTAL
Intervention: High goal group
Number of subjects: 0
Study 8859396 — intervention group
Group type: EXPERIMENTAL
Intervention: Low goal group
Number of subjects: 0
Study 8859396 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 0
Study 1363488 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose fentanyl (2 micrograms/kg) and vecuronium (120 micrograms/kg)
Number of subjects: 38
Study 1363488 — intervention group
Group type: COMPARATOR
Intervention: Atropine (control)
Number of subjects: 38
Study 1363488 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (induction agent)
Number of subjects: 38
Study 6585733 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-mg prostaglandin E2 (PGE2) vaginal suppository
Number of subjects: 0
Study 6585733 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31733777 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional treatment combined with core muscle strengthening exercises (Experimental Group)
Number of subjects: 113
Study 31733777 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment alone (Control Group)
Number of subjects: 113
Study 30672175 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination group (flipping moxibustion + acupuncture)
Number of subjects: 120
Study 30672175 — intervention group
Group type: COMPARATOR
Intervention: Flipping moxibustion group
Number of subjects: 120
Study 30672175 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture group
Number of subjects: 120
Study 27117602 — intervention group
Group type: EXPERIMENTAL
Intervention: Familiarity (6 hours exposure)
Number of subjects: 145
Study 27117602 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative stereotype (depiction as messy and clumsy)
Number of subjects: 145
Study 27117602 — intervention group
Group type: COMPARATOR
Intervention: No prior exposure (control for familiarity)
Number of subjects: 145
Study 27117602 — intervention group
Group type: COMPARATOR
Intervention: No stereotype (control for stereotype)
Number of subjects: 145
Study 25301045 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-energy coronary CT angiography
Number of subjects: 27
Study 25301045 — intervention group
Group type: COMPARATOR
Intervention: Single-energy coronary CT angiography
Number of subjects: 27
Study 22326696 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal angioplasty (PTA) with additional stent placement on indication
Number of subjects: 400
Study 22326696 — intervention group
Group type: COMPARATOR
Intervention: Supervised exercise therapy (SET)
Number of subjects: 400
Study 22326696 — intervention group
Group type: EXPERIMENTAL
Intervention: PTA
Number of subjects: 400
Study 22326696 — intervention group
Group type: COMPARATOR
Intervention: SET
Number of subjects: 400
Study 21189915 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol 5 mg once daily
Number of subjects: 60
Study 21189915 — intervention group
Group type: COMPARATOR
Intervention: (S) Atenolol 25 mg once daily
Number of subjects: 60
Study 17286093 — intervention group
Group type: EXPERIMENTAL
Intervention: Craniocervical flexion exercise (CCFEx) program
Number of subjects: 50
Study 17286093 — intervention group
Group type: COMPARATOR
Intervention: Conventional cervical flexion exercise (CFEx) program
Number of subjects: 50
Study 15622265 — intervention group
Group type: EXPERIMENTAL
Intervention: Perlane
Number of subjects: 68
Study 15622265 — intervention group
Group type: COMPARATOR
Intervention: Zyplast
Number of subjects: 68
Study 12381038 — intervention group
Group type: EXPERIMENTAL
Intervention: VRGET with no physiological feedback (VRGETno)
Number of subjects: 30
Study 12381038 — intervention group
Group type: EXPERIMENTAL
Intervention: VRGET with physiological feedback (VRGETpm)
Number of subjects: 30
Study 12381038 — intervention group
Group type: COMPARATOR
Intervention: Imaginal exposure therapy (IET)
Number of subjects: 30
Study 9928776 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency thermocoagulation at the level of the Gasserian ganglion
Number of subjects: 48
Study 7550935 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical sympathetic ganglion block (CSB) with lidocaine
Number of subjects: 4
Study 7550935 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical sympathetic ganglion block (CSB) with bupivacaine
Number of subjects: 4
Study 7550935 — intervention group
Group type: COMPARATOR
Intervention: Cervical sympathetic ganglion block (CSB) with saline
Number of subjects: 4
Study 7550935 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical sympathetic ganglion block (CSB) with lidocaine and bupivacaine
Number of subjects: 4
Study 2147405 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 21
Study 2147405 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 21
Study 2147405 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic monitor
Number of subjects: 21
Study 2147405 — intervention group
Group type: COMPARATOR
Intervention: Pill counts
Number of subjects: 21
Study 6267651 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen treatment
Number of subjects: 16
Study 6267651 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 16
Study 30489104 — intervention group
Group type: EXPERIMENTAL
Intervention: 90-day Facebook smoking cessation intervention
Number of subjects: 500
Study 30489104 — intervention group
Group type: COMPARATOR
Intervention: Control group (Smokefree.gov referral)
Number of subjects: 500
Study 28257937 — intervention group
Group type: EXPERIMENTAL
Intervention: CA: CHO + alpha-lactalbumin
Number of subjects: 10
Study 27578364 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative delirium assessment in PACU and within the first week after surgery.
Number of subjects: 850
Study 27578364 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive function assessed with a neuropsychological test battery at 1 week and 3 months post-surgery.
Number of subjects: 850
Study 27578364 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariable analysis of POCD considering predisposing and precipitating factors.
Number of subjects: 850
Study 24394594 — intervention group
Group type: EXPERIMENTAL
Intervention: Noise-reduction program (education, rules, technical devices)
Number of subjects: 156
Study 24394594 — intervention group
Group type: COMPARATOR
Intervention: Control group (no noise-reduction program)
Number of subjects: 156
Study 22459241 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyester suture augmentation
Number of subjects: 100
Study 22459241 — intervention group
Group type: COMPARATOR
Intervention: Nonaugmentation
Number of subjects: 100
Study 19288469 — intervention group
Group type: EXPERIMENTAL
Intervention: Subthalamic nucleus (STN) deep brain stimulation (DBS)
Number of subjects: 52
Study 19288469 — intervention group
Group type: EXPERIMENTAL
Intervention: Globus pallidus interna (GPi) deep brain stimulation (DBS)
Number of subjects: 52
Study 19288469 — intervention group
Group type: COMPARATOR
Intervention: Ventral stimulation
Number of subjects: 52
Study 19288469 — intervention group
Group type: COMPARATOR
Intervention: Optimal DBS setting
Number of subjects: 52
Study 19288469 — intervention group
Group type: COMPARATOR
Intervention: Off DBS
Number of subjects: 52
Study 17961204 — intervention group
Group type: EXPERIMENTAL
Intervention: PS-FO
Number of subjects: 21
Study 17961204 — intervention group
Group type: COMPARATOR
Intervention: PS-SO
Number of subjects: 21
Study 17961204 — intervention group
Group type: COMPARATOR
Intervention: PS-OO
Number of subjects: 21
Study 15995005 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin-heparin lock solution (25 microg/mL)
Number of subjects: 85
Study 12053828 — intervention group
Group type: EXPERIMENTAL
Intervention: Various treatments for solar keratoses (specific interventions not detailed in the abstract)
Number of subjects: 0
Study 9466468 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTF) 1 mg/kg as a loading dose followed by 1 mg/kg/h
Number of subjects: 12
Study 9466468 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 12
Study 7653816 — intervention group
Group type: EXPERIMENTAL
Intervention: Group I: subarachnoid injection of 12 mg hyperbaric tetracaine
Number of subjects: 20
Study 7653816 — intervention group
Group type: COMPARATOR
Intervention: Group II: no spinal injection
Number of subjects: 20
Study 2496998 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefadroxil
Number of subjects: 239
Study 2496998 — intervention group
Group type: COMPARATOR
Intervention: Penicillin
Number of subjects: 239
Study 1100300 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam, 0.5 mg
Number of subjects: 100
Study 1100300 — intervention group
Group type: EXPERIMENTAL
Intervention: Secobarbital, 100 mg
Number of subjects: 100
Study 1100300 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 29847166 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 331
Study 29847166 — intervention group
Group type: COMPARATOR
Intervention: Multiple daily injections (MDI)
Number of subjects: 331
Study 28824047 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum osteoglycin levels
Number of subjects: 383
Study 28824047 — intervention group
Group type: COMPARATOR
Intervention: Healthy control serum osteoglycin levels
Number of subjects: 383
Study 28824047 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteoglycin levels in diabetic group
Number of subjects: 383
Study 26329718 — intervention group
Group type: EXPERIMENTAL
Intervention: Silk therapeutic garments plus standard eczema care
Number of subjects: 300
Study 26329718 — intervention group
Group type: COMPARATOR
Intervention: Standard eczema care alone
Number of subjects: 300
Study 24282870 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral-B Triumph with SmartGuide (oscillating-rotating brush)
Number of subjects: 130
Study 24282870 — intervention group
Group type: COMPARATOR
Intervention: Colgate ProClinical A1500 (sonic brush)
Number of subjects: 130
Study 22013199 — intervention group
Group type: EXPERIMENTAL
Intervention: Low plasma folate concentrations (lowest quartile)
Number of subjects: 2296
Study 22013199 — intervention group
Group type: EXPERIMENTAL
Intervention: High plasma tHcy concentration
Number of subjects: 2296
Study 22013199 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma cobalamin concentration
Number of subjects: 2296
Study 18433528 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy at 1.4 ATA
Number of subjects: 60
Study 18433528 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy at 1.5 ATA
Number of subjects: 60
Study 18433528 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy at 1.6 ATA
Number of subjects: 60
Study 16487219 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 or 40 mg daily for 24 weeks
Number of subjects: 0
Study 14660810 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese herbal drug formula (n=33)
Number of subjects: 65
Study 14660810 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=32)
Number of subjects: 65
Study 11464183 — intervention group
Group type: EXPERIMENTAL
Intervention: Docosanol 10% cream
Number of subjects: 737
Study 11464183 — intervention group
Group type: COMPARATOR
Intervention: Placebo (polyethylene glycol)
Number of subjects: 737
Study 9605367 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg orally
Number of subjects: 216
Study 9605367 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine 10 mg intramuscularly
Number of subjects: 216
Study 9605367 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study 7999289 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral-B Advantage Plaque Remover
Number of subjects: 230
Study 3377059 — intervention group
Group type: EXPERIMENTAL
Intervention: 38% water content hydrogel lenses
Number of subjects: 0
Study 3377059 — intervention group
Group type: EXPERIMENTAL
Intervention: 67% water content hydrogel lenses
Number of subjects: 0
Study 3377059 — intervention group
Group type: EXPERIMENTAL
Intervention: Altered lens parameters (fitting characteristics)
Number of subjects: 0
Study 31383564 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Therapeutic Education (PTE) combined with spa therapy
Number of subjects: 340
Study 31383564 — intervention group
Group type: COMPARATOR
Intervention: Spa therapy alone (control group)
Number of subjects: 340
Study 28258537 — intervention group
Group type: EXPERIMENTAL
Intervention: SCRIPT online educational module
Number of subjects: 80
Study 28258537 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study 24196463 — intervention group
Group type: EXPERIMENTAL
Intervention: Local infiltration analgesia with 0.2% ropivacaine, ketorolac, and adrenaline followed by continuous infusion of 0.2% ropivacaine at 5 mL/hr
Number of subjects: 105
Study 24196463 — intervention group
Group type: COMPARATOR
Intervention: Local infiltration analgesia with 0.2% ropivacaine, ketorolac, and adrenaline followed by continuous infusion of saline solution at 5 mL/hr
Number of subjects: 105
Study 24196463 — intervention group
Group type: COMPARATOR
Intervention: Local infiltration with saline solution followed by continuous infusion of saline solution at 5 mL/hr
Number of subjects: 105
Study 21689412 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive strategy using periodic e-mail prompts
Number of subjects: 0
Study 21689412 — intervention group
Group type: COMPARATOR
Intervention: Reactive strategy
Number of subjects: 0
Study 19589264 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitiglinide 10-20 mg three times daily
Number of subjects: 291
Study 19589264 — intervention group
Group type: COMPARATOR
Intervention: Nateglinide 120 mg three times daily
Number of subjects: 291
Study 16485228 — intervention group
Group type: EXPERIMENTAL
Intervention: Covered sclerotomy (ST)
Number of subjects: 58
Study 16485228 — intervention group
Group type: COMPARATOR
Intervention: Covered sclerotomy with viscoelastic filling (ST+H)
Number of subjects: 58
Study 14769679 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) - nurse-managed cognitive behavioral relapse-prevention intervention at bedside, with telephone contact after discharge
Number of subjects: 277
Study 14769679 — intervention group
Group type: COMPARATOR
Intervention: Usual-Care Group (UG) - strong physician's advice, a self-help pamphlet, and a list of community resources
Number of subjects: 277
Study 11755327 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin (5 mg)
Number of subjects: 60
Study 11755327 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural S(+)‐ketamine (0.1 mg/kg)
Number of subjects: 60
Study 11755327 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural S(+)‐ketamine (0.2 mg/kg)
Number of subjects: 60
Study 11755327 — intervention group
Group type: COMPARATOR
Intervention: Control group (epidural saline and transdermal placebo)
Number of subjects: 60
Study 11755327 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin/0.1 mg/kg S(+)‐ketamine (1 NKG)
Number of subjects: 60
Study 9686072 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin (10 mg)
Number of subjects: 50
Study 9686072 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 29334615 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-paced graded exercise testing (SPV)
Number of subjects: 16
Study 29334615 — intervention group
Group type: COMPARATOR
Intervention: Ramp graded exercise testing (RAMP)
Number of subjects: 16
Study 26465374 — intervention group
Group type: EXPERIMENTAL
Intervention: Novolimus-eluting stent (NES), n=139
Number of subjects: 210
Study 26465374 — intervention group
Group type: COMPARATOR
Intervention: Zotarolimus-eluting stent (ZES), n=71
Number of subjects: 210
Study 24955623 — intervention group
Group type: EXPERIMENTAL
Intervention: Technical Skill Assessment Instrument (TSAI)
Number of subjects: 29
Study 24955623 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision study projections
Number of subjects: 29
Study 22890436 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed kinetic chain (CKC) exercises at 15 degrees of flexion
Number of subjects: 39
Study 22890436 — intervention group
Group type: EXPERIMENTAL
Intervention: Open kinetic chain (OKC) exercises at 30 degrees of flexion
Number of subjects: 39
Study 22890436 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed kinetic chain (CKC) exercises at 30 degrees of flexion
Number of subjects: 39
Study 19846891 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalic stimulation
Number of subjects: 11
Study 19846891 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham feeding
Number of subjects: 11
Study 19846891 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric retention
Number of subjects: 11
Study 19846891 — intervention group
Group type: EXPERIMENTAL
Intervention: Duodenal instillation
Number of subjects: 11
Study 19846891 — intervention group
Group type: COMPARATOR
Intervention: Control (normal ingestion)
Number of subjects: 11
Study 19846891 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflated intrapyloric balloon during satiety testing
Number of subjects: 11
Study 19846891 — intervention group
Group type: EXPERIMENTAL
Intervention: Deflated intrapyloric balloon during satiety testing
Number of subjects: 11
Study 16417534 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV) 1000 mg twice daily
Number of subjects: 94
Study 16417534 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV)
Number of subjects: 94
Study 16417534 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study 15159248 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated linoleic acid (CLA)
Number of subjects: 0
Study 15159248 — intervention group
Group type: EXPERIMENTAL
Intervention: Purified trans‐10,cis‐12 isomer of CLA
Number of subjects: 0
Study 11561046 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency repetitive transcranial magnetic stimulation (HF‐rTMS) applied to the left dorsolateral prefrontal area in daily sessions for 10 consecutive working days.
Number of subjects: 28
Study 11561046 — intervention group
Group type: COMPARATOR
Intervention: Sham HF‐rTMS
Number of subjects: 28
Study 9783947 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural and/or general anesthesia
Number of subjects: 110
Study 9783947 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 110
Study 8162718 — intervention group
Group type: EXPERIMENTAL
Intervention: Propafenone, 150 mg every 4 h
Number of subjects: 50
Study 8162718 — intervention group
Group type: COMPARATOR
Intervention: Verapamil, 40 mg every 4 h
Number of subjects: 50
Study 2832763 — intervention group
Group type: COMPARATOR
Intervention: Radiation only (2,100 cGy in seven fractions)
Number of subjects: 166
Study 2832763 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation plus iv chemotherapy (5-fluorouracil)
Number of subjects: 166
Study 2832763 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation plus intra-arterial chemotherapy (5-fluorouracil)
Number of subjects: 166
Study 30777890 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT)
Number of subjects: 1412
Study 28433557 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 73
Study 28433557 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 73
Study 26678294 — intervention group
Group type: EXPERIMENTAL
Intervention: PCHMS (Personally Controlled Health Management System)
Number of subjects: 330
Study 26678294 — intervention group
Group type: COMPARATOR
Intervention: Control group (online static educational content)
Number of subjects: 330
Study 23741444 — intervention group
Group type: EXPERIMENTAL
Intervention: Noise-based tube current with filtered back projection (Group 2, n=109)
Number of subjects: 338
Study 23741444 — intervention group
Group type: EXPERIMENTAL
Intervention: Noise-based tube current with iterative reconstruction (Group 3, n=116)
Number of subjects: 338
Study 23741444 — intervention group
Group type: EXPERIMENTAL
Intervention: Iterative reconstruction (Group 3)
Number of subjects: 338
Study 23741444 — intervention group
Group type: COMPARATOR
Intervention: Fixed tube current with filtered back projection (Group 1, n=113)
Number of subjects: 338
Study 21391876 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate cord clamping (ICC) at 5-10 s
Number of subjects: 42
Study 21391876 — intervention group
Group type: COMPARATOR
Intervention: Delayed cord clamping (DCC) at 30-45 s
Number of subjects: 42
Study 18498540 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal challenge with cow's milk protein (CM)
Number of subjects: 21
Study 18498540 — intervention group
Group type: EXPERIMENTAL
Intervention: CM-sensitive patients
Number of subjects: 21
Study 18498540 — intervention group
Group type: EXPERIMENTAL
Intervention: CM-free diet
Number of subjects: 21
Study 18498540 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 21
Study 16729787 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide aqueous nasal spray, 64 microg (32 microg per nostril) once daily for 1 year
Number of subjects: 229
Study 16729787 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 1 year
Number of subjects: 229
Study 15047457 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel and estramustine
Number of subjects: 0
Study 15047457 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel monotherapy
Number of subjects: 0
Study 15047457 — intervention group
Group type: COMPARATOR
Intervention: Mitoxantrone
Number of subjects: 0
Study 11335776 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (500 mg twice daily)
Number of subjects: 29
Study 11335776 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 9383177 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic NaCl solution (100 mmol NaCl in 50 ml) administered to untreated hypertensives
Number of subjects: 33